InsiderSignalSign in
← Insider buys
RETA

Reata Pharmaceuticals Inc

SVP, Global Regulatory Affairs Andrea Loewen sold $546K of Reata Pharmaceuticals Inc

Sold$546,181
$172.03Price
3,175Shares
−10%Stake

What RETA did after the filing

Filed Sep 18, copier in the same day
The stock from Mon, Sep 18 close, $172.05
+0.2%
S&P 500, same days
−2.6%

5 of 30 trading days so far, to the Sep 25 close.

Traded Thu, Sep 14. Filed Mon, Sep 18, 1:34 PM ET, during the session. Returns use the Sep 18 close and the Sep 25 close. Not investment advice.